AGP Picks
View all

Today in Science
Provided by AGP

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 26, 2026

Rezolve Ai to Showcase Its Infrastructure for the Agentic Economy at Nasdaq Investor Day on October 6 
Aug. 26, 2026

Rezolve Ai to Showcase Its Infrastructure for the Agentic Economy at Nasdaq Investor Day on October 6 

Indeterminate GlobeNewswire
Cerence Announces Repurchase of $10 Million of 1.50% Convertible Senior Notes Due 2028
Aug. 26, 2026

Cerence Announces Repurchase of $10 Million of 1.50% Convertible Senior Notes Due 2028

Indeterminate GlobeNewswire
Rail Vision Delivers Strong Commercial Momentum in First Half of 2026 with Revenue Exceeding $1 Million
Aug. 26, 2026

Rail Vision Delivers Strong Commercial Momentum in First Half of 2026 with Revenue Exceeding $1 Million

Indeterminate GlobeNewswire
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
Aug. 26, 2026

Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026

Indeterminate GlobeNewswire
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
Aug. 26, 2026

Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference

Indeterminate GlobeNewswire
BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM
Aug. 26, 2026

BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM

Indeterminate GlobeNewswire
Eikon Therapeutics to Participate in Investor Conferences in September 2026
Aug. 26, 2026

Eikon Therapeutics to Participate in Investor Conferences in September 2026

Indeterminate GlobeNewswire
MicrobiotiX Completes Sentinel Cohort of its First-in-human Clinical Trial of MP101 for Pneumonia
Aug. 26, 2026

MicrobiotiX Completes Sentinel Cohort of its First-in-human Clinical Trial of MP101 for Pneumonia

Indeterminate GlobeNewswire
Nexera Technologies: Subsidiary Fort Technology Closes Acquisition of Majority Stake in Logia USA to Fuel the Future of Data Centers
Aug. 26, 2026

Nexera Technologies: Subsidiary Fort Technology Closes Acquisition of Majority Stake in Logia USA to Fuel the Future of Data Centers

Indeterminate GlobeNewswire
Calian announces agreement to sell its U.S. commercial IT business to Trace3
Aug. 26, 2026

Calian announces agreement to sell its U.S. commercial IT business to Trace3

Indeterminate GlobeNewswire
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors
Aug. 26, 2026

Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors

Indeterminate GlobeNewswire
Ligand to Participate in September Investor Conferences
Aug. 26, 2026

Ligand to Participate in September Investor Conferences

Indeterminate GlobeNewswire
INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
Aug. 26, 2026

INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings

Indeterminate GlobeNewswire
Veea and Totalplay Advance Commercial Plans for Secure, AI-Powered Business Services in Mexico
Aug. 26, 2026

Veea and Totalplay Advance Commercial Plans for Secure, AI-Powered Business Services in Mexico

Indeterminate GlobeNewswire
Kashable Names Dar Miranda VP of Go-to-Market As Employer Demand for Financial Wellness Grows
Aug. 26, 2026

Kashable Names Dar Miranda VP of Go-to-Market As Employer Demand for Financial Wellness Grows

Indeterminate GlobeNewswire
Leading Independent Proxy Advisory Firm ISS Advises its Subscribers to Vote FOR All Five Questor Director Nominees on the GOLD Proxy; Questor Investor Advises the Same
Aug. 26, 2026

Leading Independent Proxy Advisory Firm ISS Advises its Subscribers to Vote FOR All Five Questor Director Nominees on the GOLD Proxy; Questor Investor Advises the Same

Indeterminate GlobeNewswire
AI Disrupts Advanced Aerospace Materials Engineering as Global Investment Surpasses $650 Billion in Infrastructure Buildout
Aug. 26, 2026

AI Disrupts Advanced Aerospace Materials Engineering as Global Investment Surpasses $650 Billion in Infrastructure Buildout

Indeterminate GlobeNewswire
Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines
Aug. 26, 2026

Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines

Indeterminate GlobeNewswire
Bitdeer Announces July 2026 Production and Operations Update
Aug. 26, 2026

Bitdeer Announces July 2026 Production and Operations Update

Indeterminate GlobeNewswire
EarthDaily Expands AI-Powered Wildfire Risk Intelligence Across the Western U.S. With North American Insurance Major
Aug. 26, 2026

EarthDaily Expands AI-Powered Wildfire Risk Intelligence Across the Western U.S. With North American Insurance Major

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Science

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.